Trans-pacific multicenter collaborative study of minimally invasive proximal versus total gastrectomy for proximal gastric and gastroesophageal junction cancers

Naruhiko Ikoma,Travis Grotz,Hirofumi Kawakubo,Hyoung-Il Kim,Satoru Matsuda,Yuki Hirata,Atsushi Nakao,Loretta A. Williams,Xin Shelley Wang,Tito Mendoza,Xuemei Wang,Brian D. Badgwell,Paul F. Mansfield,Woo-Jin Hyung,Vivian E. Strong,Yuko Kitagawa
DOI: https://doi.org/10.1186/s12893-023-02163-8
2023-09-03
BMC Surgery
Abstract:The current standard operation for proximal gastric and gastroesophageal junction (P/GEJ) cancers with limited esophageal extension is total gastrectomy (TG). TG is associated with impaired appetite and weight loss due to the loss of gastric functions such as production of ghrelin and with anemia due to intrinsic factor loss and vitamin B 12 malabsorption. Theoretically, proximal gastrectomy (PG) can mitigate these problems by preserving gastric function. However, PG with direct esophagogastric reconstruction is associated with severe postoperative reflux, delayed gastric emptying, and poor quality of life (QoL). Minimally invasive PG (MIPG) with antireflux techniques has been increasingly performed by experts but is technically demanding owing to its complexity. Moreover, the actual advantages of MIPG over minimally invasive TG (MITG) with regards to postoperative QoL are unknown. Our overall objective of this study is to determine the short-term QoL benefits of MIPG. Our central hypotheses are that MIPG is safe and that patients have improved appetite after MIPG with effective antireflux techniques, which leads to an overall QoL improvement when compared with MITG.
surgery
What problem does this paper attempt to address?